September 28, 2018 / 9:18 PM / 2 months ago

BRIEF-FDA Approves Genentech's Xolair Prefilled Syringe Formulation

1 Min Read

Sept 28 (Reuters) - Roche Holding AG:

* FDA APPROVES GENENTECH’S XOLAIR (OMALIZUMAB) PREFILLED SYRINGE FORMULATION

* GENENTECH SAYS NEW XOLAIR PFS FORMULATION IS EXPECTED TO BE AVAILABLE BY END OF THIS YEAR IN U.S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below